Informations:
Erreur:
ID
31212
Description
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).; ODM derived from: https://clinicaltrials.gov/show/NCT00760929
Lien
https://clinicaltrials.gov/show/NCT00760929
Mots-clés
Versions (1)
- 29/07/2018 29/07/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
29 juillet 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929
- StudyEvent: Eligibility
Similar models
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age | Non-Small Cell Lung Carcinoma Advanced Locally Inoperable TNM clinical staging | Non-small cell lung cancer metastatic Inoperable TNM clinical staging
Item
male or female patients >=18 years with histologically documented inoperable, locally advanced or metastatic (stage iiib or iv) nsclc;
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C0205187 (UMLS CUI [2,4])
C3258246 (UMLS CUI [2,5])
C0278987 (UMLS CUI [3,1])
C0205187 (UMLS CUI [3,2])
C3258246 (UMLS CUI [3,3])
C0007131 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C0205187 (UMLS CUI [2,4])
C3258246 (UMLS CUI [2,5])
C0278987 (UMLS CUI [3,1])
C0205187 (UMLS CUI [3,2])
C3258246 (UMLS CUI [3,3])
Chemotherapy Regimen Quantity failed
Item
patients must have failed at least one but no more than two standard chemotherapy regimens;
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease according to the recist criteria;
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status;
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy >12 weeks.
boolean
C0023671 (UMLS CUI [1])
Central nervous system lesion
Item
patients with active cns lesions;
boolean
C0742468 (UMLS CUI [1])
IGF1R Inhibitors | Pharmaceutical Preparations Targeting EGFR
Item
prior treatment with agents acting via igf-1r inhibition or egfr targeting;
boolean
C4044495 (UMLS CUI [1,1])
C0243077 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C1521840 (UMLS CUI [2,2])
C0034802 (UMLS CUI [2,3])
C0243077 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C1521840 (UMLS CUI [2,2])
C0034802 (UMLS CUI [2,3])
CORTICOSTEROIDS FOR SYSTEMIC USE High dose
Item
administration with high doses of systemic corticosteroids;
boolean
C3653708 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
radiotherapy in the 4 weeks prior to study start;
boolean
C1522449 (UMLS CUI [1])
Operative Surgical Procedures | Traumatic injury
Item
surgery or significant traumatic injury with in the last 2 weeks prior to study start.
boolean
C0543467 (UMLS CUI [1])
C3263723 (UMLS CUI [2])
C3263723 (UMLS CUI [2])